Risk, Clinical Course, and Outcome of Ischemic Stroke in Patients Hospitalized With COVID-19: A Multicenter Cohort

Wouter M Sluis1, Marijke Linschoten2, Julie E Buijs3

  • 1Department of Neurology and Neurosurgery, UMC Utrecht Brain Center (W.M.S., L.J.K., H.B.v.d.W., A.M.A.), University Medical Center Utrecht, Utrecht University, the Netherlands.

Stroke
|November 4, 2021
PubMed

Insights

The incidence of ischemic stroke in hospitalized coronavirus disease 2019 (COVID-19) patients was approximately 2%, with higher rates in intensive care units. COVID-19 stroke patients faced poor outcomes and increased mortality risk.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Cardiology

Background:

  • The frequency of ischemic stroke in COVID-19 patients is variable, with unknown risk factors.
  • Assessing stroke incidence, risk factors, and outcomes in hospitalized COVID-19 patients is crucial.

Purpose of the Study:

  • To determine the incidence, risk factors, and outcomes of acute ischemic stroke in hospitalized COVID-19 patients.
  • To compare risk factors, cardiovascular complications, and mortality between COVID-19 patients with and without ischemic stroke.

Main Methods:

  • A multicenter cohort study included 2147 hospitalized patients with laboratory-confirmed SARS-CoV-2 infection.
  • Patients were screened for acute ischemic stroke; cumulative incidence was calculated.
  • Risk factors, cardiovascular complications, and in-hospital mortality were compared between patients with and without stroke.

Main Results:

  • 1.8% (38/2147) of COVID-19 patients experienced ischemic stroke, with higher incidence in intensive care units (2.7% vs. 1.4%).
  • Stroke patients were older but lacked differing cardiovascular risk factors; pulmonary embolism was more common (21.1% vs. 7.6%).
  • 71.1% of stroke patients had poor outcomes (death or functional dependence), and stroke increased in-hospital mortality risk (aRR, 1.56).

Conclusions:

  • The cumulative incidence of ischemic stroke in hospitalized COVID-19 patients was approximately 2%, higher in ICU patients.
  • Most COVID-19 stroke patients experienced poor outcomes, highlighting the severity of this complication.
  • The association between ischemic stroke and pulmonary embolism requires further investigation.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.0K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
49
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
43
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
79
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
71
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K